Insider Selling: LifeStance Health Group (NASDAQ:LFST) Insider Sells 50,000 Shares of Stock

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Ann Varanakis sold 50,000 shares of the stock in a transaction on Wednesday, December 17th. The stock was sold at an average price of $6.90, for a total value of $345,000.00. Following the sale, the insider owned 315,610 shares of the company’s stock, valued at approximately $2,177,709. This represents a 13.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.

LifeStance Health Group Stock Up 1.6%

NASDAQ LFST traded up $0.11 on Friday, reaching $7.05. The stock had a trading volume of 9,306,414 shares, compared to its average volume of 2,042,345. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 0.18. LifeStance Health Group, Inc. has a 1 year low of $3.74 and a 1 year high of $8.30. The business has a 50 day moving average price of $5.95 and a 200 day moving average price of $5.37. The company has a market capitalization of $2.74 billion, a price-to-earnings ratio of -235.00 and a beta of 1.13.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The company had revenue of $363.81 million during the quarter, compared to the consensus estimate of $355.06 million. LifeStance Health Group had a negative return on equity of 0.62% and a negative net margin of 0.67%.The business’s quarterly revenue was up 16.3% on a year-over-year basis. During the same period last year, the business earned ($0.02) EPS. On average, analysts forecast that LifeStance Health Group, Inc. will post -0.18 EPS for the current fiscal year.

Institutional Trading of LifeStance Health Group

Large investors have recently modified their holdings of the company. Park Edge Advisors LLC acquired a new position in LifeStance Health Group in the 2nd quarter valued at $52,000. Bayesian Capital Management LP bought a new stake in LifeStance Health Group during the second quarter valued at about $52,000. Public Employees Retirement System of Ohio acquired a new stake in shares of LifeStance Health Group in the second quarter valued at about $70,000. Blair William & Co. IL acquired a new stake in shares of LifeStance Health Group in the second quarter valued at about $70,000. Finally, Vanguard Personalized Indexing Management LLC bought a new position in shares of LifeStance Health Group in the third quarter worth about $72,000. 85.50% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on LFST shares. UBS Group boosted their target price on shares of LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a research report on Friday, November 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of LifeStance Health Group in a research note on Monday. BMO Capital Markets began coverage on shares of LifeStance Health Group in a report on Thursday, November 13th. They issued an “outperform” rating and a $8.00 price objective for the company. Zacks Research downgraded shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 5th. Finally, BTIG Research raised their target price on LifeStance Health Group from $9.00 to $10.00 and gave the company a “buy” rating in a report on Friday, December 12th. Two investment analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $8.83.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.